What You See is What You Get? Imaging of Cell Therapy for Cardiac Regeneration

被引：0
作者：
Napp L.C. [1 ,3 ]
Templin C. [2 ]
机构：
[1] Department of Cardiology and Angiology, Hannover Medical School, Hannover
[2] Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich
[3] Integrated Research and Treatment Center Transplantation (IFB-Tx), Hannover Medical School, Hannover
来源：
Current Cardiovascular Imaging Reports | 2014年 / 7卷 / 1期
关键词：
BLI; Heart failure; Imaging; MRI; Myocardial infarction; PET; SPECT; Stem cells;
D O I：
10.1007/s12410-013-9243-z
中图分类号：
学科分类号：
摘要：
An estimated 7.3 million people die from coronary heart disease each year, according to the recent report of the World Health Organization. In the hope of true regeneration of the infarcted or failing heart, stem and progenitor cells from various sources have gained massive attention in recent years. Data from animal and human studies have been conflicting, and cell type and application varied significantly across all protocols. It now has become clear that many details of cardiac cell therapy remain to be elucidated. In this context comprehensive in vivo imaging methods are essential tools to evaluate mechanisms of cell engraftment and function. In the present review we summarize current imaging modalities for tracking transplanted cells in animals and humans including most recent developments in the field. © 2014, Springer Science+Business Media New York.
引用
收藏
页码：1 / 11
页数：10
相关论文
共 62 条
  • [21] Rodriguez-Porcel M., Brinton T.J., Chen I.Y., Et al., Reporter gene imaging following percutaneous delivery in swine moving toward clinical applications, J Am Coll Cardiol, 51, pp. 595-597, (2008)
  • [22] van der Spoel T.I., Jansen of Lorkeers S.J., Agostoni P., Et al., Human relevance of preclinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease, Cardiovasc Res, 91, pp. 649-658, (2011)
  • [23] Bernsen M.R., Moelker A.D., Wielopolski P.A., van Tiel S.T., Krestin G.P., Labelling of mammalian cells for visualisation by MRI, Eur Radiol, 20, pp. 255-274, (2009)
  • [24] Kostura L., Kraitchman D.L., Mackay A.M., Pittenger M.F., Bulte J.W., Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis, NMR Biomed, 17, pp. 513-517, (2004)
  • [25] Terrovitis J., Stuber M., Youssef A., Et al., Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart, Circulation, 117, pp. 1555-1562, (2008)
  • [26] Amsalem Y., Mardor Y., Feinberg M.S., Et al., Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium, Circulation, 116, pp. I38-I45, (2007)
  • [27] Gilad A.A., Winnard P.T., van Zijl P.C., Bulte J.W., Developing MR reporter genes: promises and pitfalls, NMR Biomed, 20, pp. 275-290, (2007)
  • [28] Naumova A.V., Reinecke H., Yarnykh V., Deem J., Yuan C., Murry C.E., Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart, Mol Imaging, 9, pp. 201-210, (2010)
  • [29] Gilad A.A., Walczak P., McMahon M.T., Et al., MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles, Magn Reson Med, 60, pp. 1-7, (2008)
  • [30] Tran L.A., Krishnamurthy R., Muthupillai R., Cabreira-Hansen Mda G., Willerson J.T., Perin E.C., Et al., Gadonanotubes as magnetic nanolabels for stem cell detection, Biomaterials, 31, pp. 9482-9491, (2010)
1234567